These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21644282)

  • 1. [Ten years after publishing results from The Heart Outcomes Prevention Evaluation Study--HOPE: implications on treatment with angiotensin converting enzyme inhibitors in clinical practice].
    Pocanić D
    Lijec Vjesn; 2011; 133(1-2):69-71. PubMed ID: 21644282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HOPE Study (Heart Outcomes Prevention Evaluation).
    Sleight P
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):18-20. PubMed ID: 11967789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE.
    Gerstein HC
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S82-5. PubMed ID: 12324991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and the HOPE study: implications for macrovascular and microvascular disease.
    Gerstein HC
    Int J Clin Pract Suppl; 2001 Jan; (117):8-12. PubMed ID: 11715357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.
    Can J Cardiol; 1996 Feb; 12(2):127-37. PubMed ID: 8605634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of ramipril on cardiovascular events and on diabetes: results of the HOPE study extension.
    Bosch J; Lonn E; Pogue J; Arnold JM; Dagenais GR; Yusuf S;
    Circulation; 2005 Aug; 112(9):1339-46. PubMed ID: 16129815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future perspectives and implications.
    Sleight P
    Int J Clin Pract Suppl; 2001 Jan; (117):22-3. PubMed ID: 11715355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA?
    Boos CJ
    Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding?
    Mancini GB; Stewart DJ
    Can J Cardiol; 2001 May; 17 Suppl A():15A-7A. PubMed ID: 11381289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
    Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
    Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.
    Lancet; 2000 Jan; 355(9200):253-9. PubMed ID: 10675071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ramipril on the incidence of atrial fibrillation: results of the Heart Outcomes Prevention Evaluation study.
    Salehian O; Healey J; Stambler B; Alnemer K; Almerri K; Grover J; Bata I; Mann J; Matthew J; Pogue J; Yusuf S; Dagenais G; Lonn E;
    Am Heart J; 2007 Sep; 154(3):448-53. PubMed ID: 17719288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?
    Ong HT
    J Am Board Fam Med; 2009; 22(6):686-97. PubMed ID: 19897698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the relevance of the HOPE study in general practice?
    Kennedy J; Mogensen CE; Ball SG; Castaigne AD; Commerford PJ; Distiller L; Fisher BM; Gonzalez-Jaunatey J; Nosadini R; Novials A; Ostergren J; Palma-Gámiz J; Perrone-Filardi P; Schipperheijn JJ; Senges J; Trevisan R
    Int J Clin Pract; 2001 Sep; 55(7):449-57. PubMed ID: 11594254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The HOPE Study. What does it contribute to general practice?].
    Mann J; Sleight P
    MMW Fortschr Med; 2000 Nov; 142(47):28-32. PubMed ID: 11143776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended follow-up of patients randomly assigned in the Angiotensin-converting enzyme inhibition Post-Revascularization Study (APRES).
    Kjøller-Hansen L; Steffensen R; Grande P
    Am Heart J; 2004 Sep; 148(3):475-80. PubMed ID: 15389235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.
    Cleland JG; Erhardt L; Murray G; Hall AS; Ball SG
    Eur Heart J; 1997 Jan; 18(1):41-51. PubMed ID: 9049514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of bundle branch block in high-risk chronic stable vascular disease patients: a report from the HOPE trial.
    Sumner G; Salehian O; Yi Q; Healey J; Mathew J; Al-Merri K; Al-Nemer K; Mann JF; Dagenais G; Lonn E;
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):781-7. PubMed ID: 19298567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-pressure reduction and cardiovascular risk in HOPE study.
    Sleight P; Yusuf S; Pogue J; Tsuyuki R; Diaz R; Probstfield J;
    Lancet; 2001 Dec 22-29; 358(9299):2130-1. PubMed ID: 11784631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.